-
Symbol
-
CDTX on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Ownership
-
3.02M shares
-
Security Ownership
-
9.99%
BCLS Fund III Investments, LP ownership in Cidara Therapeutics, Inc. Common Stock, $0.0001 par value per share (CDTX)
2025-11-14 - BCLS Fund III Investments, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.02M shares of Cidara Therapeutics, Inc. Common Stock, $0.0001 par value per share (CDTX).
This represents 9.99% percent ownership of the company.
In their previous filing dated 2025-08-14, BCLS Fund III Investments, LP had reported owning 2.5M shares, indicating an increase of 20.8% percent.